thymine has been researched along with alpha-synuclein in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbieri, S; Bilbe, G; Danner, S; Hofele, K; Kauffmann, S; Mistl, C; Probst, A; Sommer, B; Spooren, W; Tolnay, M; van der Putten, H; Wiederhold, KH | 1 |
| Athanassiadou, A; Bonifati, V; Di Iorio, G; Golbe, LI; Johnson, WG; Markopoulou, K; Papapetropoulos, S; Spychala, JR; Stenroos, ES; Vance, JM; Watts, RL; Williams, TA | 1 |
| Chiba-Falek, O; Glenn, OC; Linnertz, C; Lutz, MW; Roses, AD; Saul, R | 1 |
1 review(s) available for thymine and alpha-synuclein
| Article | Year |
|---|---|
Mouse models of alpha-synucleinopathy and Lewy pathology. Alpha-synuclein expression in transgenic mice.
Topics: Adenine; alpha-Synuclein; Alzheimer Disease; Animals; Brain; Disease Models, Animal; Humans; Lewy Bodies; Mice; Mice, Transgenic; Mutation; Nerve Tissue Proteins; Parkinson Disease; Point Mutation; Synucleins; Thymine | 2001 |
2 other study(ies) available for thymine and alpha-synuclein
| Article | Year |
|---|---|
Glutathione S-transferase polymorphisms and onset age in alpha-synuclein A53T mutant Parkinson's disease.
Topics: Adenine; Adult; Age of Onset; Aged; Aged, 80 and over; Alleles; alpha-Synuclein; Glutathione Transferase; Haplotypes; Humans; Middle Aged; Mutant Proteins; Parkinson Disease; Polymorphism, Genetic; Thymine | 2007 |
A cytosine-thymine (CT)-rich haplotype in intron 4 of SNCA confers risk for Lewy body pathology in Alzheimer's disease and affects SNCA expression.
Topics: Aged; Aged, 80 and over; alpha-Synuclein; Alzheimer Disease; Cytosine; Female; Gene Expression Regulation; Haplotypes; Humans; Introns; Lewy Body Disease; Polymorphism, Single Nucleotide; Risk; RNA, Messenger; Thymine | 2015 |